Thomas S. G. Sehested

Thomas S. G. Sehested
Zealand University Hospital · Department of Cardiology

Medical Doctor

About

42
Publications
1,987
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
376
Citations

Publications

Publications (42)
Article
Aim We investigated temporal trends in major cardiovascular events following first-time myocardial infarction (MI) and trends in revascularization and pharmacotherapy from 2000-2017. Methods and results Using nationwide registries, we identified 120,833 Danish patients with a first-time MI between 2000 and 2017. We investigated 30-day and 1-year m...
Article
Background Influenza vaccination protects against morbidity and mortality in patients with cardiovascular disease (CVD). We aimed to describe influenza vaccine uptake in patients with CVD in a universal-access healthcare system. Methods Using nationwide Danish registries, we included all patients with prevalent CVD, defined as heart failure (HF),...
Article
Full-text available
Background: Unstable angina (UA) is a component of acute coronary syndrome that is only occasionally included in primary composite endpoints in clinical cardiovascular trials. The aim of this paper is to elucidate the potential benefits and disadvantages of including UA in such contexts. Summary: UA comprises <10% of patients with acute coronary...
Article
Aim Over the past decades there has been improvements in the management of cardiovascular (CV) disease and risk factors. Long-term contemporary data on population-level incidence of myocardial infarction (MI), heart failure (HF), and CV mortality in patients with peripheral artery disease (PAD) is sparse, which we aim to investigate in the present...
Article
Background and aims Few studies have determined whether the declining incidence of myocardial infarction carries into the current decade, and how it is affected by age and sex. We aimed to determine age- and sex-specific changes in myocardial infarction incidence in Denmark from 2005 through 2021. Methods First-time myocardial infarction admission...
Article
Full-text available
To assess whether anthropometric measures (body mass index [BMI], waist-hip ratio [WHR], and estimated fat mass [EFM]) are independently associated with major adverse cardiovascular events (MACE), and to assess their added prognostic value compared with serum total-cholesterol. The study population comprised 109,509 individuals (53% men) from the M...
Article
Background Over the past decades there has been a shift in cardiovascular (CV) risk factors with improved outcomes. Updated trends in incidence of myocardial infarction (MI) and heart failure (HF) in peripheral artery disease (PAD) are warranted. Purpose We aimed to investigate trends in the incidence of MI, HF, and CV mortality in PAD patients du...
Article
Full-text available
Background Guideline‐based cardioprotective medical therapy is intended to reduce the burden of adverse cardiovascular and limb outcomes in patients with peripheral artery disease (PAD). However, contemporary data describing trends in use of medication remains limited. The present study, therefore, aims to investigate changes in use of cardioprotec...
Article
Increasing parity is associated with an increased risk of ischemic heart disease (IHD) and stroke in women. This is likely attributed to biological responses of pregnancy. Male cells of presumed fetal origin are commonly present in women years after pregnancy—a phenomenon termed male origin microchimerism. Here, we investigated whether male origin...
Article
Background Peripheral artery disease (PAD) is associated with increased cardiovascular (CV) morbidity and mortality. Aggressive management of risk factors and lifestyle modification may improve outcomes for patients with PAD. The present study aims to investigate changes in use of cardioprotective medication after the incident diagnosis of PAD betw...
Article
Full-text available
Background: Treatment with beta-blockers is currently recommended after myocardial infarction (MI). The evidence relies on trials conducted decades ago before implementation of revascularization and contemporary medical therapy or in trials enrolling patients with heart failure or reduced left ventricular ejection fraction (LVEF ≤ 40%). Accordingl...
Article
The Reference Values for Arterial Stiffness Collaboration has derived an equation using age and mean blood pressure to estimated pulse wave velocity (ePWV), which predicted cardiovascular events independently of Systematic COoronary Risk Evaluation (SCORE) and Framingham Risk Score. The study aim was to investigate the independent association betwe...
Article
Full-text available
Objective The risk of atrial fibrillation (AF) and stroke in patients with peripheral artery disease (PAD) is an important issue that has not been investigated adequately. Our aim with the present study was to explore trends in the incidence of AF and stroke in patients with PAD. Methods We employed Danish nationwide registers to identify all pati...
Article
Background: The use and clinical outcomes of fractional flow reserve (FFR) measurement in patients with stable ischemic heart disease (SIHD) are uncertain, as prior studies have been based on selected populations. Objectives: This study sought to evaluate contemporary, real-world patterns of FFR use and its effect on outcomes among unselected pa...
Article
Full-text available
Background: The risk of peripheral artery disease (PAD) in patients with diabetes mellitus (DM) and coronary artery disease (CAD) is an important and inadequately addressed issue. Our aim is to examine the impact of DM on risk of PAD in patients with different degrees of CAD characterized by coronary angiography (CAG). Methods: Using nationwide...
Conference Paper
Introduction The incidence rate of atrial fibrillation (AF) has increased substantially throughout the last decades. Socioeconomic factors such as income and education are well known to be associated with the development of cardiovascular disease, however, the impact on long-term trends of AF incidence rates is yet to be described. Purpose This na...
Conference Paper
Background Upper gastrointestinal bleeding following myocardial infarction continues to be a severe complication associated with increased mortality; however, bleeding events might be avoided by appropriate therapy with proton pump inhibitors. Purpose To develop and validate a prediction model aimed at identifying patients at increased risk of upp...
Conference Paper
Objectives The risk of atrial fibrillation (AF) and stroke in patients with peripheral artery disease (PAD) is an important and inadequately addressed issue. Our aim was to examine temporal trends in the incidence of AF and stroke in patients with PAD. Methods Danish nationwide registers were used to identify all patients aged ≥18 years, with firs...
Article
Aims: Guidelines differ in their recommendations on therapy to prevent gastrointestinal bleeding for patients treated with dual antiplatelet treatment (DAPT). We sought to investigate the effectiveness of proton pump inhibitors (PPIs) to prevent upper gastrointestinal (UGI) bleeding in patients using DAPT following myocardial infarction (MI) in re...
Article
Importance In the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial, the anti-inflammatory monoclonal antibody canakinumab significantly reduced the risk of recurrent cardiovascular events in patients with previous myocardial infarction (MI) and high-sensitivity C-reactive protein (hs-CRP) levels of 2 mg/L or greater. Objective...
Article
Full-text available
Aim: Warfarin is a cornerstone for the prevention of thromboembolism in atrial fibrillation (AF), and several efforts have been taken to increase its usage and safety, including risk stratification schemes. Our aim was to investigate the temporal trends in initiation of warfarin and its effects on incidence of bleeding and thromboembolism in patien...
Data
Length of grace period and the effect on TE rate. (DOCX)
Data
Temporal trends of TE, bleeding and warfarin not excluding patients with multiple antithrombotic drug use during the grace period. (DOCX)
Data
Definition of risk factors according to ACC/AHA/ESC 2006 Guidelines. (DOCX)
Data
Flowchart. Flowchart of the exclusions. (DOCX)
Data
Length of grace period and the effect on warfarin estimate. (DOCX)
Data
Length of grace period and the effect on bleeding rate. (DOCX)
Article
We read with interest the letter from Dai et al. pertaining to our recent observational study.[1] First, due to the inherent nature of observational studies, interpretations of causality remain speculative. Consequently, although the study presents extensive analyses to account for possible biases, we acknowledge the potential skewing of results du...
Article
Background: Use of proton pump inhibitors (PPIs) has been associated with cardiovascular disease among patients not on antiplatelet therapy. The associations of PPI use, duration and dose, with risk of first-time ischemic stroke and myocardial infarction (MI) are poorly understood. Methods: All Danish individuals with no prior history of MI or s...
Article
Full-text available
Background—Knowledge about drug–drug interactions commonly arises from preclinical trials, from adverse drug reports, or based on knowledge of mechanisms of action. Our aim was to investigate whether drug–drug interactions were discoverable without prior hypotheses using data mining. We focused on warfarin–drug interactions as the prototype. Metho...
Article
Full-text available
Background: Being overweight or obese is associated with a greater risk of coronary heart disease and stroke compared with normal weight. The role of the specific adipose tissue-derived substances, called adipocytokines, in overweight- and obesity-related cardiovascular disease (CVD) is still unclear. Objective: To investigate the associations o...
Article
Although overweight and obesity are associated with cardiovascular disease (CVD), it is unclear which clinical measure of overweight and obesity is the strongest predictor of CVD, and it is unclear whether the various measures of overweight and obesity are indeed independent predictors of CVD. This study was a prospective population-based study of...
Article
Full-text available
Objective: Adolescents and young adults born preterm have elevated blood pressure (BP).1,2 Little is known about the emergence of high BP in young children surviving extremely preterm birth (EXPT). Methods: Population-based cohort study of 76 EXPT (gestational age 23–26 weeks, mean birth weight 814 [161] g) surviving to a corrected postnatal age of...

Network

Cited By

Projects